Influenza Educational Initiative HOME     |     CME     |     FEEDBACK

Presented by The Johns Hopkins University School of Medicine

Made possible by an independent educational grant from Roche

In collaboration with Gullapalli & Associates, LLC

CME/CNE Posttests

Please see Calendar of Events for current programs.

Presented by The Johns Hopkins University School of Medicine

Supported by an independent educational grant from Roche

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Duration of Program: Please go to IEI Programs for specific dates by program.

Program Description:
Infectious diseases have always existed, and continue to challenge the ways in which medical practitioners approach disease management.  New infectious diseases emerge and old diseases reemerge as microbes adapt to new hosts and new environments. Although remarkable advances have been made in science and medicine during the past century, we are constantly reminded that we live in a universe of such microbes: viruses, bacteria, protozoa and fungi that are forever changing and adapting themselves to the human host and the defenses that humans create.  To remain one step ahead of these pathogenic microbial foes, we must understand in detail how they interact with their hosts, and how biological, environmental, and social factors combine to allow them to infect new organisms.

Influenza is fundamentally a recurring disease that reemerges annually in a slightly different form. However, it occasionally presents as a newly emerging disease, very different from what was previously experienced. Seasonal influenza kills about 250,000 to 500,000 people worldwide each year, mostly older individuals; despite annual vaccinations, the U.S. faces a burden of influenza that results in approximately 36,000 deaths and more than 200,000 hospitalizations each year. In addition to this human toll, influenza is responsible for a total annual cost of over $10 billion in the US.  In addition to the ever-present and largely predictable threat of seasonal influenza, the world now faces the threat of a much more unpredictable pandemic influenza, caused by the emergence of a new strain of influenza virus to which humans have never been exposed.
Influenza viruses are notable for their resilience and adaptability. While the scientific community has been able to develop highly effective vaccines and treatments for many infectious diseases that threaten public health, acquiring these tools for the influenza virus is an ongoing challenge. Changes in the genetic makeup of the virus require the development of new vaccines on an annual basis to forecast those strains that are likely to predominate.

An influenza pandemic will place a huge burden on the US healthcare system. Published estimates based on extrapolation of the 1957 and 1968 pandemics suggest that there could be anywhere from 839,000 to 9,625,000 hospitalizations, 18–42 million outpatient visits, and 20–47 million additional illnesses, depending on the attack rate of infection during the pandemic. Estimates based on extrapolation from the more severe 1918 pandemic suggest that substantially more hospitalizations and deaths could occur. The demand for inpatient and intensive-care unit (ICU) beds and assisted ventilation services could increase by more than 25% under the less severe scenario. Pre-pandemic planning by healthcare facilities is therefore essential to provide effective, uninterrupted care to ill persons and to prevent further spread of infection. Successful planning and implementation will depend on close collaboration among state and local health departments, community partners, and neighboring and regional healthcare facilities.

Therefore, the goal of the Influenza Educational Campaign is to provide hospital administrators, epidemiologists, and other related healthcare professionals with the most up-to-date information, clinical data and a plan of action for an influenza pandemic through a variety of integrated educational media and programs.

Intended Audience:

The Influenza Educational Campaign will seek to educate hospital administrators, epidemiologists, emergency room physicians, primary care physicians, infectious disease specialists, pharmacists, nurses/nurse practitioners, physician assistants and other related healthcare professionals.


There are no prerequisites to participate in this educational activity.

Learning Objectives:

  1. Examine the impact of seasonal and pandemic influenza on the healthcare system
  2. Identify the risk factors and warning signs for specific influenza epidemics/pandemics, in particular avian influenza
  3. Describe specific measures for managing and preparing for an influenza pandemic
  4. Explain pandemic influenza planning and management strategies within various healthcare settings


“It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.  Detailed disclosure will be made in the course handout materials.”

Course Format:

For details on each program within this initiative, please go to IEI Programs.

Contact Us Privacy Policy Disclosures